Inventor · disambiguated record
Henning Lauterbach
Also filed as: LAUTERBACH HENNING
7 granted patents·8 pending applications·6 citations·filing 2013–2023
74Inventor score
Top patents by PatentIndex Score
15 records- 0186US10973892B2Methods and compositions for enhancing vaccine immune responsesBAVARIAN NORDIC AS·Filed 2013·Granted Apr 13, 2021·5 cites·15 claims
- 0272US12390515B2Therapy for treating cancer with an intratumoral or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40LBAVARIAN NORDIC AS·Filed 2019·Granted Aug 19, 2025·1 cites·12 claims
- 0367US11723964B2Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVABAVARIAN NORDIC AS·Filed 2022·Granted Aug 15, 2023·0 cites·9 claims
- 0462US2025002606A1Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVABAVARIAN NORDIC AS·Filed 2023·Application pending·0 cites
- 0561US2021299236A1Methods and Compositions for Enhancing Vaccine Immune ResponsesBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 0661US2025057931A1Combination therapy with arenavirus particles and immune checkpoint modulators or cytokinesHOOKIPA BIOTECH GMBH·Filed 2023·Application pending·0 cites
- 0759US11273211B2Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibodyBAVARIAN NORDIC AS·Filed 2018·Granted Mar 15, 2022·0 cites·9 claims
- 0859US2025073324A1Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapiesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0958US11338030B2Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogensBAVARIAN NORDIC AS·Filed 2020·Granted May 24, 2022·0 cites·12 claims
- 1056US2024174724A1Arenaviruses used in treatments of prostate cancerHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1149US2023346906A1Cancer treatment strategies using arenavirus vectorsHOOKIPA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1246US10576141B2Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of useBAVARIAN NORDIC AS·Filed 2015·Granted Mar 3, 2020·0 cites·12 claims
- 1346US2023190922A1Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating CancerBAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1444US2024269254A1Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or AgonistBAVARIAN NORDIC AS·Filed 2019·Application pending·0 cites
- 1532US10512684B2Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellinBAVARIAN NORDIC AS·Filed 2015·Granted Dec 24, 2019·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →